AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2024
Oct 22, 2024
30786_dirs_2024-10-22_fbeed96a-7925-4e2d-89e9-f41e2cf04aa7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2024-10-20
Reporting Person: EVRAN SEDAT (EVP, Global Supply Chain)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-10-20 | Bio-Rad A Common Stock | M | 1044 | — | Acquired | 1188.1400 | Direct |
| 2024-10-20 | Bio-Rad A Common Stock | F | 335 | $346.37 | Disposed | 853.1400 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-10-20 | Restricted Stock Units | $0 | M | 1044 | Disposed | Bio-Rad A Common Stock (1044) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 49.0480, 41.3870 and 33.7050 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2023, 03/31/2024 and 06/30/2024, respectively.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.